| Shashikala Ameneni, MD | |
|
1400 S Dobson Rd, Mesa, AZ 85202-4707 | |
| (480) 648-7895 | |
| (480) 648-7895 |
| Full Name | Shashikala Ameneni |
|---|---|
| Gender | Female |
| Speciality | Infectious Disease |
| Experience | 27 Years |
| Location | 1400 S Dobson Rd, Mesa, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346229895 | NPI | - | NPPES |
| 724593 | Medicaid | AZ | |
| 2996281 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 30598 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Banner Desert Medical Center | Mesa, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Desert Valley Infectious Disease Physicians | 4183856982 | 8 |
News Archive
People who rate themselves as highly knowledgeable about a new infectious disease threat could also be more likely to believe they don't know enough, a new study suggests.
GW Pharmaceuticals plc, a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Application Serial Number 12/996,124, a patent which covers the use of cannabinoids for treating glioma.
The U.S. Food and Drug Administration today approved Marqibo (vincristine sulfate liposome injection) to treat adults with a rare type of leukemia called Philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL). ALL is a rapidly progressing form of blood and bone marrow cancer that is more commonly diagnosed in children than adults.
It's like a Fitbit on steroids. Researchers at Missouri University of Science and Technology have developed a multi-modal sensing device that can track the fine-grained activities and behavior of people with dementia — and it could help in Army combat training, too.
Merck, the second biggest international drug maker, is being investigated by two U.S. federal agencies for potentially breaking anti-bribery laws in foreign countries, The Associated Press reports.
› Verified 5 days ago
| Entity Name | Desert Valley Infectious Disease Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356553986 PECOS PAC ID: 4183856982 Enrollment ID: O20140409001937 |
News Archive
People who rate themselves as highly knowledgeable about a new infectious disease threat could also be more likely to believe they don't know enough, a new study suggests.
GW Pharmaceuticals plc, a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Application Serial Number 12/996,124, a patent which covers the use of cannabinoids for treating glioma.
The U.S. Food and Drug Administration today approved Marqibo (vincristine sulfate liposome injection) to treat adults with a rare type of leukemia called Philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL). ALL is a rapidly progressing form of blood and bone marrow cancer that is more commonly diagnosed in children than adults.
It's like a Fitbit on steroids. Researchers at Missouri University of Science and Technology have developed a multi-modal sensing device that can track the fine-grained activities and behavior of people with dementia — and it could help in Army combat training, too.
Merck, the second biggest international drug maker, is being investigated by two U.S. federal agencies for potentially breaking anti-bribery laws in foreign countries, The Associated Press reports.
› Verified 5 days ago
| Entity Name | East Valley Infectious Disease Medicine Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508643628 PECOS PAC ID: 9739531518 Enrollment ID: O20240117001919 |
News Archive
People who rate themselves as highly knowledgeable about a new infectious disease threat could also be more likely to believe they don't know enough, a new study suggests.
GW Pharmaceuticals plc, a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Application Serial Number 12/996,124, a patent which covers the use of cannabinoids for treating glioma.
The U.S. Food and Drug Administration today approved Marqibo (vincristine sulfate liposome injection) to treat adults with a rare type of leukemia called Philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL). ALL is a rapidly progressing form of blood and bone marrow cancer that is more commonly diagnosed in children than adults.
It's like a Fitbit on steroids. Researchers at Missouri University of Science and Technology have developed a multi-modal sensing device that can track the fine-grained activities and behavior of people with dementia — and it could help in Army combat training, too.
Merck, the second biggest international drug maker, is being investigated by two U.S. federal agencies for potentially breaking anti-bribery laws in foreign countries, The Associated Press reports.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shashikala Ameneni, MD Po Box 16303, Phoenix, AZ 85011-6303 Ph: (602) 369-1941 | Shashikala Ameneni, MD 1400 S Dobson Rd, Mesa, AZ 85202-4707 Ph: (480) 648-7895 |
News Archive
People who rate themselves as highly knowledgeable about a new infectious disease threat could also be more likely to believe they don't know enough, a new study suggests.
GW Pharmaceuticals plc, a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Application Serial Number 12/996,124, a patent which covers the use of cannabinoids for treating glioma.
The U.S. Food and Drug Administration today approved Marqibo (vincristine sulfate liposome injection) to treat adults with a rare type of leukemia called Philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL). ALL is a rapidly progressing form of blood and bone marrow cancer that is more commonly diagnosed in children than adults.
It's like a Fitbit on steroids. Researchers at Missouri University of Science and Technology have developed a multi-modal sensing device that can track the fine-grained activities and behavior of people with dementia — and it could help in Army combat training, too.
Merck, the second biggest international drug maker, is being investigated by two U.S. federal agencies for potentially breaking anti-bribery laws in foreign countries, The Associated Press reports.
› Verified 5 days ago
Dr. Emmanuel A Bayongan, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1400 S Dobson Rd, Mesa, AZ 85202 Phone: 480-543-2034 Fax: 480-512-6089 | |
Dr. Sanjeev Gopal, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 6424 E Broadway Rd, 104-105, Mesa, AZ 85206 Phone: 602-802-8700 Fax: 602-802-8799 | |
Mouhsen H Alhakeem, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1400 S Dobson Road, Attn Amanda Gump/hospitalist, Mesa, AZ 85202 Phone: 480-412-6788 Fax: 480-412-6848 | |
Dr. Bindu Jayavelu, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 301 S Power Rd Ste 103, Mesa, AZ 85206 Phone: 480-325-7535 Fax: 480-325-7462 | |
Mr. Robert Bobek Arashahi, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 5652 E Baseline Rd, Mesa, AZ 85206 Phone: 480-477-7166 | |
Mr. Robert P Tully, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 7525 E Broadway Rd, Ste 2, Mesa, AZ 85208 Phone: 480-981-9800 Fax: 480-985-9465 | |
Joshua D Cohen, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 6750 E Baywood Ave, 301, Mesa, AZ 85206 Phone: 480-835-6100 Fax: 480-461-4261 |